Navigation Links
Array BioPharma To Present Clinical Data On ARRY-797 At The 2012 American College Of Rheumatology Annual Meeting
Date:11/6/2012

ndpoint in a randomized, placebo-controlled and active-controlled (oxycodone ER) Phase 2 clinical trial in 157 osteoarthritis patients suffering from moderate to severe knee pain despite the use of non-steroidal anti-inflammatory drugs (NSAIDs).  Patients in all treatment groups continued using NSAIDs throughout the trial. ARRY-797 is a novel, oral, selective p38 inhibitor with a mechanism of action unique from that of currently approved pain medications.  Given our internal focus on hematology/oncology, Array is in active discussions with potential partners to maximize the value of this drug.

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small‑molecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company, with two wholly‑owned programs, ARRY-614 and ARRY-520, and three partnered programs, selumetinib (with AstraZeneca), MEK162 (with Novartis), and danoprevir (with InterMune / Roche), having the potential to begin Phase 3 or pivotal trials by the end of calendar year 2013.  For more information on Array, please go to www.arraybiopharma.com.

Forward-Looking Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements about the timing of the announcement of the results of clinical trials and the development plans for ARRY-797, expectations that events will occur that will result in greater value for the Company, the potential for the results of ongoing preclinical and clinical trials to support regulatory approval or the marketing success of ARRY-797, and our ability to partner ARRY-797for up-front fees, milestone and/or royalty payments and to maximize the value for Array. These statements involve significant risks and uncert
'/>"/>

SOURCE Array BioPharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2013
2. Global Array Instrument Market is Expected to Reach USD 3.2 Billion Globally in 2017: Transparency Market Research
3. PDL BioPharma Announces Third Quarter 2012 Financial Results
4. PDL BioPharma to Announce Third Quarter 2012 Financial Results on November 5, 2012
5. New Study Highlights Enabling Factors for Biopharmaceutical Innovation in Middle-Income Countries
6. SAFC Enters South Korean BioPharma Market with CrystalGenomics Agreement
7. Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team
8. Regeneron Named Worlds #1 Biopharmaceutical Employer in Science Magazine Annual Survey
9. Biopharmaceutical Industry Veterans Join Inspiration Biopharmaceuticals Board of Directors
10. PDL BioPharma Completes Regular Quarterly Dividend Payment
11. Chester County Biopharmaceutical Firm to Expand, Create 151 New Jobs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... According to a new ... Material, Application (Healthcare, Homeland security, Industrial application, Nuclear ... Hand-Held Instruments, Fixed, and Installed Instruments) & Geography ... by MarketsandMarkets, the Scintillator Market is expected to ... to 2020, and reach $479.16 Million in 2020. ...
(Date:7/11/2014)... 2014 According to a new ... Market (Endoscopes, Endoscopic Operative Devices, and Visualization Systems) - ... 2013-2019" the global endoscopy devices market was valued at ... grow at a CAGR of 6.8% from 2013 to ... billion in 2019. Browse the full Endoscopy ...
(Date:7/10/2014)... MUMBAI, India , July 11, 2014 /PRNewswire/ ... the treatment of cancer are being highlighted in ... Mumbai from 10-12 July, 2014.  Renowned ... meeting to share best practices and exchange knowledge ... more precise, accurate and efficient. ...
Breaking Medicine Technology:Scintillator Market will be worth $479.16 Million by 2020 2Scintillator Market will be worth $479.16 Million by 2020 3Scintillator Market will be worth $479.16 Million by 2020 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5
... , NEW BRUNSWICK, N.J., Dec. 17 ... has opened the 2010 call for nominations. The $100,000 ... contributions towards the improvement of human health. Nomination ... be accepted until February 15, 2010. The Award winner ...
... LITTLE FALLS, N.J., Dec. 17 CANTEL MEDICAL CORP. ... Directors intends to pay, for the first time, a semiannual cash ... on the Company,s common stock. The Board declared the first cash ... paid on January 29, 2010 to shareholders of record at the ...
Cached Medicine Technology:Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research 2Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research 3Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research 4Cantel Medical Authorizes Semiannual Dividend 2
(Date:7/13/2014)... 13, 2014 Recently, 2014QuinceaneraDresses.com, the ... unveiled its new range of gorgeous Quinceanera ... the demand for elegant Quinceanera outfits is huge. ... items. All the company’s newly released dresses are ... are all elegant and vivid. , It ...
(Date:7/13/2014)... Recently, MyDressCity.com, one of the most popular suppliers of ... its new range of elegant Quinceanera dresses . ... discounted prices. Worldwide clients can enjoy this special offer ... online shop, there are plenty of beautiful dresses for ... materials. MyDressCity.com’s hot items are prom gowns, bridesmaid gowns, ...
(Date:7/13/2014)... 13, 2014 Epidemiologists forecast an increase ... 6MM, from 8,062 diagnosed incident cases in 2013 to ... Growth Rate (AGR) of 4.35%, during the forecast period. ... of diagnosed incident cases of aGVHD in the 6MM, ... the lowest number of diagnosed incident cases of aGVHD, ...
(Date:7/13/2014)... ability to identify odors might indicate the development ... of the eye could indicate the build-up of ... brain, according to the results of four research ... Conference 2014 (AAIC 2014) in Copenhagen. , In ... identify odors was significantly associated with loss of ...
(Date:7/13/2014)... Wright & Schulte LLC has learned that the ... of 2015, in U.S. District Court, District of South ... process in the South Carolina federal court where ... multidistrict litigation (MDL). The complaints pending in the Louisiana ... that they took the statin medication to lower their ...
Breaking Medicine News(10 mins):Health News:2014QuinceaneraDresses.com Releases Its New Quinceanera Dresses 2Health News:Cheap Elegant Quinceanera Dresses Unveiled by MyDressCity.com 2Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 2Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 3Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 4Health News:Smell and eye tests show potential to detect Alzheimer's early 2Health News:Smell and eye tests show potential to detect Alzheimer's early 3Health News:Smell and eye tests show potential to detect Alzheimer's early 4Health News:Smell and eye tests show potential to detect Alzheimer's early 5Health News:Smell and eye tests show potential to detect Alzheimer's early 6Health News:Smell and eye tests show potential to detect Alzheimer's early 7Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 2Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 3Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 4
... Antares, parent company, Medical Mutual of Ohio to ... processes, reduced costs, improved ... Software, developer of the,OnBase document and process management ... Management Solutions as the new provider of,enterprise document ...
... LISTERINE(R) Products Launch New Children,s Fluoride Rinse, with Special Tinting ... ... MORRIS PLAINS, N.J., March 11 Parents confess that kids,can ... care.,According to a recent survey of parents with children ages six ...
... of EUSA,s Transatlantic ... Commercialization Platform ... EUSA Raises Over US$50 Million to Fund Acquisition and Other ... Pharma Inc (,EUSA,), a transatlantic specialty pharmaceutical company,focused on oncology, ...
... LifeMasters Supported,SelfCare, Inc., a national leading ... announced it has received $15 million in ... one of its,earliest investors, Saints Capital, and ... financial flexibility to continue to execute on,its ...
... Will Address Attorney Weight Loss Coaching and Present Ideas On How ... ... Leventhal Weight Loss,Incorporated, the first in the nation executive weight ... that its president and founder Mark Leventhal, Esq. will address,the Washington, ...
... Made to Deny Union for Healthcare Employees in Ohio, ... (CNA) has launched an anti-union campaign against nurses,and other ... by the workers to unite in District 1199 of ... votes -- this Wednesday and Friday at nine Catholic,Healthcare ...
Cached Medicine News:Health News:Antares Management Solutions Selects Hyland Software's OnBase 2Health News:The Disappearing Toothbrush: Survey Reveals Kids' Top Excuses to Avoid Brushing 2Health News:The Disappearing Toothbrush: Survey Reveals Kids' Top Excuses to Avoid Brushing 3Health News:The Disappearing Toothbrush: Survey Reveals Kids' Top Excuses to Avoid Brushing 4Health News:EUSA Pharma to Acquire US Specialty Oncology Company Cytogen 2Health News:EUSA Pharma to Acquire US Specialty Oncology Company Cytogen 3Health News:EUSA Pharma to Acquire US Specialty Oncology Company Cytogen 4Health News:EUSA Pharma to Acquire US Specialty Oncology Company Cytogen 5Health News:LifeMasters Strengthens Capital Structure with $15 Million in Funding from Existing Investors 2Health News:LifeMasters Strengthens Capital Structure with $15 Million in Funding from Existing Investors 3Health News:Mark Leventhal To Address Nixon Peabody LLP 2Health News:SEIU: 'Union-Busting' by California Nurses Association 2
3 mm, 130 degree upwards cutting, detachable....
Sabre 180 is a powerful niche generator....
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator....
The ExcaliburPlus PC is the most powerful isolated ESU with 10,000 V PTP in spray coag....
Medicine Products: